This site is intended for healthcare professionals

Go to /sign-in page

You can view 5 more pages before signing in

Go to /pro/cpd-dashboard page

This page is worth 0.05 CPD credits. CPD dashboard

Go to /account/subscription-details page

This page is worth 0.05 CPD credits. Upgrade to Pro

Inhaled steroids and steroid treatment cards

Authoring team

High doses of inhaled steroids and steroid treatment cards

People using prolonged high doses of inhaled steroids should routinely be provided with steroid treatment cards. High doses of steroids include:

  • people on 'off-label' high doses of inhaled steroids
  • people who receive a combination of maximum licensed dose of inhaled steroid and other steroids (such as oral steroids)
  • people who use inhaled corticosteroids together with medication which inhibit their metabolism e.g. - cytochrome P450 inhibitors (HIV protease inhibitors)
  • other high risk people (at the discretion of the prescriber/pharmacist) (1)

People who have inadequate control of the disease despite receiving maximal inhaled corticosteroid therapy and additional other therapies should be referred to a specialist (1).

Reference:

  1. 1. MHRA. High dose inhaled steroids: new advice on supply of steroid treatment cards. Current Problems in Pharmacovigilence 2006;31

Create an account to add page annotations

Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2024 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.